Sponsored Links

 

Displaying cisplatin PowerPoint Presentations



NSCLC Approved 1st + 2nd Line Rx - Food and Drug Administration PPT

Presentation Summary : NSCLC Approved 1st & 2nd Line Rx Vinorelbine vs 5-FU/LV Navelbine/cisplatin Gemcitabine/cisplatin Paclitaxel/cisplatin Docetaxel/cisplatin Docetaxel - 2nd line ...

Source : http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm123836.ppt

TRACO: Cancer Treatment - National Cancer Institute PPT

Presentation Summary : Lung Cancer Demographics Second most frequently diagnosed cancer in the United States ~12% of ... SCLC cisplatin and etoposide are most easily combined within ...

Source : http://ncifrederick.cancer.gov/About/Section508/Examples/Giaccone08SCLC.ppt

Alimta - Smith College PPT

Presentation Summary : Alimta (Pemetrexed) Presented By: Rachael Germansky Overview Alimta Overview Cancer Lung Cancer Mesothelioma Alimta Alimta and Cisplatin Future Applications Alimta ...

Source : http://www.science.smith.edu/departments/Biochem/Chm_357/presentations/Alimta.ppt

Primary Chemoradiation Therapy with Cisplatin/5-FU for ... PPT

Presentation Summary : Title: Primary Chemoradiation Therapy with Cisplatin/5-FU for Locally Advanced HNSCC Author: dzaboli1 Last modified by: BMESSING Created Date: 9/2/2010 8:36:57 PM

Source : http://www.gbmc.org/workfiles/HeadNeck/GBMC_Primary%20CRT%20HNSCC_Brizel%20Cohort_Grand%20Rounds_12_4_2010.ppt

Chemotherapy and Renal Toxicity - UCLA Nephrology PPT

Presentation Summary : ... Cisplatin Clinical manifestations Acute kidney injury Hypomagnesemia from urinary magnesium wasting Fanconi-like syndrome Salt wasting Prevention of ...

Source : http://www.nephrology.med.ucla.edu/MiscFiles/diseasereview/Lau%20Chemotherapy%20Renal%20Toxicity.ppt

Neo-adjuvant chemotherapy in Squamous cell carcinoma of head ... PPT

Presentation Summary : Neoadjuvant Chemotherapy in Locally Advanced Squamous Cell Cancer of Head and Neck ... Dosage of Cisplatin in CRT 80% of pts tolerated > or = 6 doses of 30 mg/m2 weekly.

Source : http://www.gbmc.org/workfiles/HeadNeck/ENT%20grandround%201-2011.ppt

Drug - Device Combination Issues : DODP Perspective PPT

Presentation Summary : Drug - Device Combination Issues ... Cisplatin Labels which include indications for use in combination with cisplatin for NSCLC gemcitabine paclitaxel ...

Source : http://www.fda.gov/downloads/CombinationProducts/MeetingsConferencesWorkshops/ucm118194.ppt

Review of Conventional Chemotherapy Drugs PPT

Presentation Summary : ... docetaxel nab-paclitaxel Topoisomerase II inhibitors etoposide Platinum Complexes cisplatin, carboplatin oxaliplatin Anthracyclines doxorubicin, ...

Source : http://chicago.medicine.uic.edu/UserFiles/Servers/Server_442934/Image/Hematology/ppt/conv_chem.ppt

Interactions in Clinical Practice: Drug-supplement, Drug Nutrient PPT

Presentation Summary : N-acetylcysteine and Cisplatin: Diverse Protective Effects NAC protects renal cells against cisplatin by inhibiting GGT, needed for nephrotoxic effects.

Source : http://www.mdheal.org/healthprofessionals/ppt/supplementsandchemotherapy.ppt

Twice-Daily Compared with Once-Daily Thoracic RT in Limited ... PPT

Presentation Summary : Title: Twice-Daily Compared with Once-Daily Thoracic RT in Limited Stage SCLC Treated Concurrently with Cisplatin & Etoposide NEJM 1999; 340: 265-271

Source : http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/clinical-departments/radiation-medicine/presentations-publications/upload/Limited-Stage-Small-Cell-Lung-Carcinoma-Overview-with-Focus-on-Management.ppt

Cancer Chemotherapy PPT

Presentation Summary : Cancer Chemotherapy Chapter 42 Steps to Cancer Initation = impt change introduced into cell Probably through DNA alteration >1 event probably needed for tumor prod ...

Source : http://clt.astate.edu/agrippo/s06lect7CancerChemotherapy.ppt

PowerPoint Presentation PPT

Presentation Summary : (mechlorethamine, cyclophosphamide, cisplatin) Induction of DNA repair enzymes (cisplatin, alkylators, bleomycin, any drug that damages DNA) ...

Source : https://courses.washington.edu/chat543/lectures/PowerPointSlides/CC_Resist%20Tox_07.ppt

Ovarian Cancer - University of Kentucky PPT

Presentation Summary : Epithelial Ovarian Cancer Christopher P. DeSimone, M.D. Associate Professor Gynecologic Oncology Department of Obstetrics & Gynecology Consolidation Chemotherapy ...

Source : http://www.mc.uky.edu/obg/Divisions/GynOnc/ONC/2011%20Epithelial%20Ovarian%20Cancer_Dr%20DeSimone.ppt

HOTTOPICS IN CHEMOTHERAPY 2011 PPT

Presentation Summary : Example: Cisplatin and paclitaxel. Can this be extrapolated? Cell Cycle. ... Chemotherapy SIG Coordinator and current SIG Webmaster, in response to the.

Source : http://chemotherapy.vc.ons.org/file_depot/0-10000000/0-10000/3365/folder/87592/Syllabus+Slides.8.2011+.FINAL.ppsx

Chemotherapy Drugs - Washington Association of Nurse ... PPT

Presentation Summary : Title: Chemotherapy Drugs Author: Cavanaugh Home Last modified by: meyersmr Created Date: 10/18/2008 9:12:26 PM Document presentation format: On-screen Show

Source : http://www.wana-crna.org/Chemo%20drugs%20case%20presentation.ppt

RECENT ADVANCES IN COMBINATION CHEMOTHERAPY: METASTATIC COLON ... PPT

Presentation Summary : Title: RECENT ADVANCES IN COMBINATION CHEMOTHERAPY: METASTATIC COLON CANCER Author: David Ilson Last modified by: ilsond Document presentation format

Source : http://elcon.imedex.com/ELC/2012/6239/6239_Ilson.ppt

Clinical Trials in Ovarian Cancer PPT

Presentation Summary : Clinical Trials in Ovarian Cancer. Ovarian Cancer Coalition Regional Conference. November 5, 2010. ... Cisplatin (75 mg/m2 q21d x 6) PLUS. Cyclophosphamide (750 mg/m2)

Source : http://www.ovariancancer.org/wp-content/uploads/2010/11/Clinical-Trials-talk-for-Regional-Conf-FINAL-VERSION-copy.ppt

Ovarian cancer PPT

Presentation Summary : Ovarian Cancer in the ... for Newly Diagnosed Ovarian Cancer Complete surgical staging Optimal reductive surgery Chemotherapy Platinum = cisplatin or ...

Source : http://ccr.cancer.gov/careers/courses/traco/documents/TRACO%20Ovarian%20Cancer%202011.508.R.ppt

Prognostic Value of p53, Glutathione S-Transferase and ... PPT

Presentation Summary : Title: Prognostic Value of p53, Glutathione S-Transferase and Thymidylate Synthase for Neoadjuvant Cisplatin and 5-Fluorouracil Chemotherapy in Head and Neck Cancer

Source : http://fha.dhmh.maryland.gov/cancer/cancerplan/archives/conf2004/Cancer%20Centers/Cullen.ppt

Ovarian cancer PPT

Presentation Summary : Ovarian Cancer in the Genomics Era Christina M. Annunziata, ... 83% completed 6 cycles 2. Intraperitoneal therapy, Cisplatin 100 mg/m2 IP d1 Paclitaxel 135 mg/m2 ...

Source : http://ccr.cancer.gov/careers/courses/traco/documents/Annunziata508TRACO2012.ppt

Audiometric Monitoring for Ototoxicity - ENT for the PA-C PPT

Presentation Summary : Audiometric Monitoring for Ototoxicity Alan I. Segal, ... Mechanisms of Cisplatin Ototoxicity Hearing loss affected by free radical formation and anti-oxidant ...

Source : http://2011entforpac.files.wordpress.com/2011/01/audiometric_monitoring_for_ototoxicity0118-vers-3-new-ppt.ppt

Chemotherapy-Induced Peripheral Neuropathy: Why the complication? PPT

Presentation Summary : Cisplatin can unfortunately be long-lasting, and take even years to resolve. Click the arrow below to advance to the next slide. Rest and Review!

Source : http://faculty.alverno.edu/bowneps/MSN621/2008%20tutorials/Chemotherapy-Induced%20Peripheral%20Neuropathy%20tutorial.ppt

Sponsored Links
If you find powerpoint presentation a copyright It is important to understand and respect the copyright rules of the author.
Please do not download if you find presentation copyright.
If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com